About the Company:Our client (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company dedicated to developing and commercializing transformative medicines for oncology, infectious diseases, and autoimmune diseases. Our R&D leaders are internationally recognized as
Electrogenos is at the forefront of the ClimateTech industry, striving to create a cleaner future for our planet. Our mission is to revolutionize green hydrogen production, aiming to reduce its cost to just $1 per kilogram